ctrl K

Price Alert

Fulcrum Therapeutics Inc. (FULC)

NASDAQ: FULC · Real-Time Price · USD

6.81

0.21 (3.18%)

At close: Aug 15, 2025, 3:59 PM

6.82

0.15%

After-hours: Aug 15, 2025, 04:10 PM EDT

Fulcrum Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	58.21M	25.56M	35.1M	35.41M
Short-Term Investments	182.81M	210.66M	167.82M	182.75M
Long-Term Investments	n/a	n/a	1.09M	1.09M
Other Long-Term Assets	1.21M	3.1M	2.1M	542K
Receivables	3.34M	2.25M	1.08M	4.11M
Inventory	n/a	n/a	-852K	-473K
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	249.92M	242.2M	207.52M	226M
Property-Plant & Equipment	9.58M	12.39M	15.97M	7.37M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	10.79M	15.49M	19.17M	9M
Total Assets	260.72M	257.69M	226.69M	235M
Account Payables	1.16M	2.76M	3.64M	4.79M
Deferred Revenue	n/a	n/a	934K	4.71M
Short-Term Debt	n/a	n/a	2.6M	n/a
Other Current Liabilities	463K	396K	2.74M	4.71M
Total Current Liabilities	11.04M	13.68M	16.73M	19.2M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	197K	197K	197K	4.26M
Total Long-Term Liabilities	6.64M	8.83M	11.02M	4.26M
Total Liabilities	17.68M	22.5M	27.74M	23.46M
Total Debt	8.63M	10.82M	13.42M	n/a
Common Stock	54K	62K	52K	41K
Retained Earnings	-519.4M	-509.67M	-412.34M	-302.47M
Comprehensive Income	130K	-136K	-797K	-397K
Shareholders Equity	243.03M	235.19M	198.94M	211.54M
Total Investments	182.81M	210.66M	167.82M	182.75M